Alexander disease is a rare genetic disorder that progressively damages the nervous system, particularly affecting the brain’s white matter and causing symptoms that can appear at any stage of life, from infancy through adulthood.

Understanding Alexander Disease

Alexander disease belongs to a group of conditions known as leukodystrophies, which are disorders that damage the white matter in the brain. White matter is a network of nerve fibers that helps brain and nerve cells communicate with each other throughout the body. When this communication system breaks down, the consequences can affect every aspect of a person’s physical and mental functioning.^[1]

What makes Alexander disease particularly distinctive is the accumulation of abnormal protein clumps called Rosenthal fibers within specialized brain cells called astrocytes. Astrocytes are support cells that normally help maintain the health of nerve cells, provide them with nutrients, and support the formation and maintenance of myelin—the fatty protective coating that surrounds nerve fibers. When Rosenthal fibers build up in astrocytes, these cells can no longer perform their vital functions properly, leading to damage of the myelin sheath and disruption of nerve signal transmission.^[2]

The disease was first described in 1949 by physician W. Stewart Alexander, who treated a 15-month-old infant presenting with an enlarged brain, fluid buildup in the brain, seizures, and developmental delays. Over the following years, more cases with similar symptoms were identified, leading to the condition being named after Dr. Alexander.^[4]

Epidemiology

Alexander disease is extremely rare, affecting an estimated 1 in 1 million people in the United States. Since its first description in 1949, approximately 500 cases have been reported worldwide. This makes it one of the rarer leukodystrophies, though the actual number of cases may be higher due to underdiagnosis or misdiagnosis.^[5][14]

The disease does not show preference for any particular ethnic group, race, geographic region, or socioeconomic background. It affects males and females equally, without any notable difference in frequency between the sexes. This universal distribution suggests that the genetic mutations responsible for the disease can occur spontaneously in any population.^[4][6]

The infantile form is the most commonly diagnosed type of Alexander disease, typically appearing before age 2. However, the true epidemiology remains challenging to establish due to the disease’s rarity and the fact that some cases, particularly those with later onset, may be misdiagnosed as other neurological conditions such as Parkinson’s disease or multiple sclerosis.^[2]

Causes

Most cases of Alexander disease are caused by mutations in the GFAP gene, which stands for glial fibrillary acidic protein. This gene provides instructions for producing a protein that forms part of the structural framework inside astrocyte cells. In healthy individuals, GFAP proteins link together to form intermediate filaments that provide support and strength to astrocytes, enabling them to maintain the brain’s white matter and support nerve cell function.^[1]

When the GFAP gene mutates, it produces an abnormal version of the glial fibrillary acidic protein. Instead of forming proper supportive structures, the mutant protein accumulates abnormally within astrocytes, creating the characteristic Rosenthal fibers. These protein clumps disrupt the normal functioning of astrocytes, preventing them from properly maintaining myelin and supporting nerve cells. The result is progressive damage to the white matter and impaired communication between nerve cells throughout the brain and spinal cord.^[8]

The GFAP gene is located on chromosome 17q21, and approximately 90 percent of individuals with Alexander disease have an identifiable mutation in this gene. The remaining 10 percent of cases do not show mutations in GFAP, which suggests that there may be other genetic or possibly non-genetic causes of the disease that researchers have yet to identify.^[6][11]

Risk Factors

Anyone can develop Alexander disease, as it typically occurs through a new, spontaneous genetic mutation rather than being inherited from parents. In the vast majority of cases, the GFAP gene mutation appears randomly, meaning it happens without any family history of the condition. This spontaneous occurrence means that parents of a child with Alexander disease usually have a very low risk of having another affected child.^[7]

However, Alexander disease is inherited in an autosomal dominant pattern when it does run in families. This means that only one copy of the mutated gene is needed to cause the disease. In these rare familial cases, if a parent carries the GFAP mutation, there is a 50 percent chance of passing the mutated gene to each child. Adult-onset forms of Alexander disease may be more likely to show familial inheritance patterns compared to infantile forms.^[2]

There are no known environmental, behavioral, or lifestyle factors that increase the risk of developing Alexander disease. The mutations occur randomly during the formation of reproductive cells or in early embryonic development. This means that nothing a parent does or does not do can cause or prevent the genetic mutation that leads to Alexander disease.^[9]

For families with a history of Alexander disease or other leukodystrophies, genetic counseling can provide valuable information about the risk of passing the condition to future children. Some families may consider preimplantation genetic diagnosis, a procedure performed during in vitro fertilization that can identify embryos carrying genetic mutations before pregnancy begins.^[2]

Symptoms

The symptoms of Alexander disease vary significantly depending on when they first appear, with earlier onset generally associated with more severe manifestations. Healthcare providers classify the disease into four types based on the age at onset: neonatal, infantile, juvenile, and adult forms. Each type presents with its own characteristic pattern of symptoms, though there can be considerable overlap.^[2]

Neonatal and Infantile Alexander Disease

The neonatal form develops during the first month of life, while the infantile form affects children before age 2. The infantile form is the most common type of Alexander disease. Children with these early-onset forms typically experience developmental delays, meaning they are slow to reach expected milestones such as sitting up, crawling, or walking. Speech development may also be significantly delayed.^[9]

Megalencephaly, or an abnormally enlarged brain and head size, is a common feature of infantile Alexander disease. This enlargement may be accompanied by hydrocephalus, which is a buildup of fluid within the brain. Seizures frequently occur and can be difficult to control. Many children also develop spasticity, characterized by stiff muscles, involuntary muscle movements, or muscle spasms that affect their ability to move normally. Growth faltering, where children fail to gain weight and grow at the expected rate, is another concerning symptom.^[2]

Juvenile-Onset Alexander Disease

The juvenile form typically appears between ages 2 and 13, with symptoms most commonly beginning between ages 4 and 10. Children with this form may experience difficulty swallowing and speaking, which can affect their ability to eat safely and communicate effectively. Frequent vomiting is common and may lead to nutritional concerns.^[9]

Muscle problems are prominent in juvenile Alexander disease, particularly affecting the legs. Children may experience muscle weakness, pain, or spasms that make walking and other physical activities challenging. Many develop kyphoscoliosis, which involves abnormal front-to-back and side-to-side curvature of the spine. While some children experience slowed mental functioning, this does not occur in all cases, and cognitive abilities may remain relatively preserved in some individuals.^[2]

Adult-Onset Alexander Disease

Adult-onset Alexander disease can develop any time after the late teen years and is the least common form. Symptoms tend to be milder and progress more slowly than in earlier-onset forms. Adults may experience symptoms similar to those in juvenile disease, including speech and swallowing difficulties, muscle problems, and poor coordination. Additionally, they may develop tremors, sleep disturbances, and problems with balance, coordination, and movements known as ataxia.^[2]

In some cases, adult-onset Alexander disease symptoms can mimic those of other neurological conditions such as Parkinson’s disease or multiple sclerosis, or may even present primarily as a psychiatric disorder. This can make diagnosis challenging and may lead to delays in identifying the true cause of symptoms.^[4]

Prevention

Because Alexander disease is caused by genetic mutations that occur spontaneously or are inherited, there are currently no known methods to prevent the condition from developing. The random nature of most GFAP gene mutations means that they cannot be anticipated or avoided through lifestyle changes, dietary modifications, or other preventive measures.^[7]

For families with a known history of Alexander disease, genetic counseling offers an opportunity to understand the inheritance patterns and assess the risk of passing the condition to future children. Genetic counselors can explain the autosomal dominant inheritance pattern and discuss reproductive options, including preimplantation genetic diagnosis for couples undergoing in vitro fertilization.^[2]

Currently, there are no vaccines, supplements, or screening programs that can prevent Alexander disease. Research into the disease mechanisms continues, with scientists working to understand how the GFAP mutations cause damage and exploring potential therapeutic approaches. These research efforts may eventually lead to strategies that could slow or halt disease progression, even if prevention of the initial genetic mutation remains impossible.^[11]

Pathophysiology

The pathophysiology of Alexander disease involves a cascade of cellular and molecular events that begin with the mutation of the GFAP gene. Under normal circumstances, the GFAP gene produces proteins that assemble into intermediate filaments within astrocytes. These filaments provide structural support and help astrocytes perform their many functions, including maintaining the myelin sheath that protects nerve fibers.^[1]

When a mutation alters the GFAP gene, the resulting abnormal protein cannot form proper intermediate filaments. Instead, the mutant protein accumulates within astrocytes, creating abnormal protein deposits known as Rosenthal fibers. These fibers contain large quantities of GFAP along with other proteins. The accumulation of Rosenthal fibers disrupts the normal structure and function of astrocytes, essentially clogging up the cellular machinery and preventing these support cells from carrying out their vital roles.^[8]

As astrocytes become dysfunctional due to the buildup of Rosenthal fibers, they can no longer properly maintain the myelin sheath that insulates nerve fibers. Myelin is essential for the rapid and efficient transmission of electrical signals along nerve fibers. When myelin deteriorates or is not properly maintained, the speed and accuracy of nerve signal transmission decreases dramatically. This breakdown in communication between nerve cells leads to the wide range of neurological symptoms seen in Alexander disease.^[5]

The disease affects not only the cells that express the mutant protein but also other cell types throughout the brain. This widespread impact occurs because astrocytes interact with and support many different types of brain cells, including neurons and oligodendrocytes (the cells that produce myelin). When astrocytes malfunction, the ripple effects extend throughout the nervous system, causing progressive neurological deterioration.^[12]

The timing and severity of symptoms appear to correlate with the extent and location of white matter damage and Rosenthal fiber accumulation. In infantile forms, widespread white matter abnormalities are typically evident, while in adult-onset forms, there may be little to no visible white matter pathology, even though Rosenthal fibers are still present. This variation helps explain why the disease manifests so differently depending on the age of onset.^[3]